Adrenomedullin and Its Receptors Are Expressed in Mouse Pancreatic β-Cells and Suppresses Insulin Synthesis and Secretion

Authors

Yuanlin Dong
Simone Hernandez Ruano
Akansha Mishra
Kathleen A Pennington
Chandrasekhar Yallampalli

Publication Date

1-1-2022

Journal

PLoS One

DOI

10.1371/journal.pone.0265890

PMID

35324977

PMCID

PMC8947024

PubMedCentral® Posted Date

3-24-2022

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Keywords

Adrenomedullin, Animals, Diabetes, Gestational, Female, Glucose, Humans, Insulin, Insulin, Regular, Human, Insulin-Secreting Cells, Mice, Pregnancy, Receptors, Adrenomedullin

Abstract

Gestational diabetes mellitus (GDM) is associated with defective pancreatic β-cell adaptation in pregnancy, but the underlying mechanism remains obscure. Our previous studies demonstrated that GDM women display increased plasma adrenomedullin (ADM) levels, and non-obese GDM mice show decreased serum concentrations of insulin and the number of β-cells in pancreas islets. The aims of this study is to examine if ADM and its receptors are expressed in female mouse pancreas, and if so, whether insulin secretion is regulated by ADM in mouse β-cell line, NIT-1 cells and isolated mouse pancreatic islets. Present study shows that ADM and its receptor components CRLR, RAMPs are present in mouse pancreatic islets and co-localized with insulin. The expressions of ADM, CRLR and RAMP2 in islets from pregnant mice are reduced compared to that of non-pregnant mice. NIT-1-β cells express ADM and its receptor mRNA, and glucose dose-dependently stimulates expressions. Furthermore, ADM inhibits NIT-1-β cell growth, and this inhibition is reversed by ADM antagonist, ADM22-52. The glucose-induced insulin secretion was suppressed by ADM in NIT-1-β cells and isolated pancreatic islets from pregnant mice. These inhibitory effects are accompanied by upregulation of endoplasmic reticulum (ER) stress biomarker genes in NIT-1-β cells. This study unveils that reduced ADM and its receptors may play a role in β-cell adaptation during pregnancy, while increased plasma ADM in GDM may contribute to the β-cells dysfunction, and blockade of ADM may reverse β-cell insulin production.